Patent directory · USPTO A61K / A61P
Patents matching “Sangamo Therapeutics, Inc.”
106 pharma patents match "Sangamo Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 106 pharmaceutical patents matching "Sangamo Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9877988
Method of treating lysosomal storage diseases using nucleases and a transgene
granted -
US 9834787
Targeted integration into stem cells
granted -
US 9833479
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
granted -
US 9816074
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
granted -
US 9783827
DNA-binding proteins and uses thereof
granted -
US 9782437
Methods and compositions for targeted cleavage and recombination
granted -
US 9777281
Methods and compositions for regulation of transgene expression
granted -
US 9771403
Methods and compositions for treating hemophilia
granted -
US 9757420
Gene editing for HIV gene therapy
granted -
US 9717759
Modification of CXCR4 using engineered zinc finger proteins
granted